The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
26.47
-1.01 (-3.68%)
Jan 31, 2025, 4:00 PM EST - Market closed

The Pennant Group Revenue

The Pennant Group had revenue of $180.69M in the quarter ending September 30, 2024, with 28.89% growth. This brings the company's revenue in the last twelve months to $652.30M, up 24.58% year-over-year. In the year 2023, The Pennant Group had annual revenue of $544.89M with 15.14% growth.

Revenue (ttm)
$652.30M
Revenue Growth
+24.58%
P/S Ratio
1.22
Revenue / Employee
$112,641
Employees
5,791
Market Cap
909.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023544.89M71.65M15.14%
Dec 31, 2022473.24M33.55M7.63%
Dec 31, 2021439.69M48.74M12.47%
Dec 31, 2020390.95M52.42M15.49%
Dec 31, 2019338.53M52.47M18.34%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 63.17B
AbbVie 56.33B
Novartis AG 51.72B
AstraZeneca 51.21B
Thermo Fisher Scientific 42.88B
Abbott Laboratories 41.95B
Revenue Rankings